TY  - JOUR
T1  - Atrial fibrillation ablation, symptoms, and stroke risk: Comment on “discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (discern af)”
AU  - Kazi DS, Hlatky MA
Y1  - 2013/01/28
N1  - 10.1001/jamainternmed.2013.2476
JO  - JAMA Internal Medicine
SP  - 156
EP  - 157
VL  - 173
IS  - 2
N2  - 
The public health burden of atrial fibrillation (AF) is considerable: AF affects an estimated 2.6 million Americans1 and increases the risk for ischemic stroke 2- to 7-fold, likely as a result of thromboemboli from the left atrium. Most patients require treatment with anticoagulants to reduce the risk for stroke, but these therapies increase the risk for bleeding. Many but not all patients with AF experience arrhythmia-related symptoms such as palpitations, syncope, and reduced-exercise capacity. Thus, the therapy for AF aims to reduce arrhythmia-related symptoms and the risk for ischemic stroke.

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.2476
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.2476
ER  -